Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos

Beatriz Villarejo-Zori (Lead / Corresponding author), Juan Zapata-Muñoz, Elena Sierra-Filardi, Ignacio Ramírez-Pardo, Lambert Montava-Garriga, Ian G. Ganley, Patricia Boya (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Photoreceptor degeneration is the hallmark of retinitis pigmentosa. Identifying general mechanisms underlying photoreceptor cell death is key to developing effective, mutation-independent treatments to prevent vision loss. Mitophagy is a protective pathway that prevents age-dependent vision loss and is upregulated by iron chelators such as deferiprone (DFP). Therefore, we aimed to investigate the ability of DFP to protect against retinal degeneration via mitophagy. First, we treated mitophagy reporter mice with MNU, a classic inducer of photoreceptor degeneration. MNU induced retinal degeneration and comprehensively inhibited mitophagy, while also inducing lysosomal basification and lysosomal membrane permeabilization. Although DFP rescued cells and retinal explants from the toxic effects of MNU, this effect was independent of mitophagy. Further investigation revealed that PAR polymers accumulation associated with parthanatos cell death was reduced to similar extents by DFP and the PARP inhibitor olaparib. In conclusion, iron chelation can protect against MNU-induced photoreceptor degeneration in retinal explants via parthanatos inhibition. (Figure presented.)

Original languageEnglish
Article number402
JournalCell Death and Disease
Volume16
Issue number1
Early online date19 May 2025
DOIs
Publication statusPublished - 2025

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos'. Together they form a unique fingerprint.

Cite this